BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.220
-0.050 (-3.94%)
Dec 26, 2025, 2:46 PM EST - Market open
BioVie Market Cap
BioVie has a market cap or net worth of $9.2 million as of December 26, 2025. Its market cap has decreased by -81.23% in one year.
Market Cap
9.20M
Enterprise Value
-15.07M
1-Year Change
-81.23%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $9.20M, a decrease of -82.32%. That is a compound annual growth rate of -28.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 9.60M | -72.96% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |